| News |
![]()
|
CARDIFF NAMED 'FAST ... | | | ASTRAZENECA SELECTS ... | | | VERITY NAMES TODD K.... |
![]()
|
![]() |
![]() |
![]() |
AstraZeneca Selects Autonomy's Technology To Assist In Global Drug Development And Product Delivery
All areas of the company - from R&D to business management to benefit from automated knowledge management system
CAMBRIDGE, England, 10th August 2000 - Autonomy today announced that AstraZeneca, the major international pharmaceutical company known for its research and products in many critical disease areas, including oncology, gastrointestinal and cardiovascular diseases, has adopted Autonomy's Portal-in-a-Box™ product to automatically manage and personalise information to help in the fight against chronic illnesses.
Using Portal-in-a-Box™, AstraZeneca will be able to automatically categorise information from a wide range of internal and external sources - the Web, the Intranet, internal documents and e-mails - and deliver it to the appropriate users in real time, as the information becomes available.
The ability to manage information automatically in this way enables users to cut through the growing volume of unstructured information - Web pages, Intranet pages, e-mails, word processing files - that characterise today's businesses. The volume of information on the Web alone is doubling every three months; within enterprises, one in five companies has had to increase its network resources by 75% or more to manage its growing corporate information.
At the heart of Autonomy's software is a pattern recognition technology, which has the ability to analyse a piece of text and identify the main ideas. This enables the software to then determine how the text should be categorised, who should see it, what other relevant material it should be linked to, and how it should be tagged - which all happens automatically.
Duncan Fyfe, Director of Informatics, Product Strategy and Licensing at AstraZeneca, commented: "The growing volume of unstructured information in any enterprise is threatening to overwhelm the users of that information. By using Autonomy, we can ensure that the right material reaches the right person at the right time. This in turn means that our staff are better informed, our research decisions better supported, and the costs typically associated with managing information significantly reduced."
Dr. Mike Lynch, Group CEO of Autonomy, said: "Astra Zeneca has recognised that its need to manage vast amounts of information and tailor it to individual users cannot be addressed using only manual or keyword-based approaches. Autonomy gives AstraZeneca the edge by enabling it to manage its information automatically, on the basis of content. This makes for more effective knowledge management and translates ultimately into more rapid advances in research."
About Autonomy Corporation plc
Autonomy's technology powers large-scale, personalised systems for the Enterprise, Internet and other Digital domains. Because of its ability to analyse any piece of text (independent of the document's language) and identify and rank the main ideas, Autonomy can automate a broad range of otherwise labor intensive tasks. These range from categorising information by subject matter, to inserting hypertext links to related material, to profiling users based on the ideas in the text they read or write, to delivering information to those most likely to be interested.
Autonomy (EASDAQ/NASDAQ: AUTN) was founded in 1996 and has offices in Boston, Chicago, Dallas, San Francisco, New York, and Washington, D.C. in the United States, as well as offices in Amsterdam, Brussels, Cambridge, England, Frankfurt, Milan, Paris, Oslo and Sydney.
Among its 200-plus customers are Alcatel, Associated Press, Barclays Bank, British Aerospace, Clorox, News Corp., Lucent Technologies, Merrill Lynch, SF Gate, Reuters Semi-tech, The Royal Mail, Unilever, and the United States Department of Defense. In addition, several software companies are licensing Autonomy's technology to add intelligence to their online publishing, knowledge management, email routing and document management applications, including Aeneid, Brio, CoreChange, Delano, Filenet, FutureTense, Hyperwave, Insight, Intranet Solutions, Intraspect, KnowledgeTrack, Global Recall, Nexor, Novient, OpenMarket, Sagemaker, Sybase, Verge and Vignette.
About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $15 billion and leading positions in sales of gastrointestinal, oncology, anaesthesia including pain management, cardiovascular, central nervous system (CNS) and respiratory products.
Note:
With the exception of historical information, the matters set forth in this news release are forward-looking statements that involve risks and uncertainties. A number of important factors could cause actual results to differ materially from those in the forward-looking statements. These factors include, among others, dependence on core technology; limited operating history; fluctuations in quarterly results; dependence on new product development; rapid technological and market change; reliance on sales by others; management of growth; dependence on key personnel; rapid expansion; technology risks; volatility of stock price; growth of the Internet; financial risk management; and future growth subject to risks. These factors and other factors which could cause actual results to differ materially are also discussed in the company's filings with the United States Securities and Exchange Commission, including Autonomy's Registration Statement on Form F-1, File no. 333-11804.
| For more information, please contact: |
|
AUTONOMY CORPORATION plc Dr. Mike Lynch, Managing Director and CEO Ralph Harms, Chief Financial Officer Dominic Johnson, Marketing Director Tel: 01223 421220 |
Forthcoming Events
Archived Events
| Power Webinar |
This is a selection of our forthcoming events, please visit our seminars page for more information.
Automatic Hyperlinks provided by IDOL Server 10
|
|
|
|
|
|
|
|
|
|
|
|
This is a small selection of the Autonomy case studies available, please visit our publications site at http://publications.autonomy.com/ for more information.
Automatic Hyperlinks provided by IDOL Server 10
























































Find us on Facebook
Follow us on Twitter
See us on YouTube
Find us on LinkedIn







